Procedure for assessing the behavioral effects of novel anti-parkinsonian drugs in normal and MPTP-treated marmosets following central microinfusions
- 1 April 1991
- journal article
- Published by Elsevier in Journal of Pharmacological Methods
- Vol. 25 (2) , 123-131
- https://doi.org/10.1016/0160-5402(91)90003-n
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's diseasePsychopharmacology, 1990
- Stereoselective reversal of MPTP-induced parkinsonism in the marmoset after dermal application of N-0437European Journal of Pharmacology, 1989
- Antiparkinsonian activity of CY 208–243, a partial D‐1 dopamine receptor agonist, in MPTP‐treated marmosets and patients with Parkinson's diseaseMovement Disorders, 1989
- Behavioural effects of (+)-4-propyl-9-hydroxynaphthoxazine in primates rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridineNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1988
- A reliable, rapid and inexpensive method for producing and implanting chronic cannulae into brains of small animalsPharmacology Biochemistry and Behavior, 1986
- Failure of SKF 38393‐A to relieve parkinsonian symptoms induced by 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine in the marmosetBritish Journal of Pharmacology, 1985
- Pargyline Prevents MPTP-Induced Parkinsonism in PrimatesScience, 1984
- Construction and implantation of a permanent cannula for making injections into the lateral ventricle of the rat brainLife Sciences, 1966